Stock Scorecard
Stock Summary for Zynex Inc (ZYXI) - $11.23 as of 4/25/2024 3:43:10 PM EST
Total Score
10 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ZYXI
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ZYXI
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ZYXI
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for ZYXI
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for ZYXI
Financial Details for ZYXI
Company Overview |
|
|---|---|
| Ticker | ZYXI |
| Company Name | Zynex Inc |
| Country | USA |
| Description | Zynex, Inc. designs, manufactures and markets medical devices to treat chronic and acute pain; and activating and exercising muscles for rehabilitation purposes with electrical stimulation. The company is headquartered in Englewood, Colorado. |
| Sector Name | LIFE SCIENCES |
| Industry Name | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 11.23 |
| Last Day Price Updated | 4/25/2024 3:43:10 PM EST |
| Last Day Volume | 127,688 |
| Average Daily Volume | 133,404 |
| 52-Week High | 14.75 |
| 52-Week Low | 6.88 |
| Last Price to 52 Week Low | 63.23% |
Valuation Measures |
|
| Trailing PE | 41.59 |
| Industry PE | 47.62 |
| Sector PE | 61.73 |
| 5-Year Average PE | 25.13 |
| Free Cash Flow Ratio | 8.02 |
| Industry Free Cash Flow Ratio | 21.57 |
| Sector Free Cash Flow Ratio | 30.74 |
| Current Ratio Most Recent Quarter | 4.74 |
| Total Cash Per Share | 1.40 |
| Book Value Per Share Most Recent Quarter | 1.38 |
| Price to Book Ratio | 8.24 |
| Industry Price to Book Ratio | 3.23 |
| Sector Price to Book Ratio | 22.08 |
| Price to Sales Ratio Twelve Trailing Months | 2.06 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.52 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
| Total Shares Outstanding | 31,929,700 |
| Market Capitalization | 358,570,531 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 1/5/2022 |
| Last Dividend Amount | 0.06 |
| Current Dividend Amount | 0.10 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 1 |
| 3-Year Average Dividend Yield | 0.72% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 57.14% |
| 3-Year Dividend Growth Rate Percentage | -14.37% |
| 5-Year Dividend Growth Rate Percentage | -14.37% |
| All-Time Dividend Growth Rate Percentage | -14.37% |
| Dividend Payout Ratio | 0.00% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -81.90% |
| Annual Earnings Growth | -42.91% |
| Reported EPS 12 Trailing Months | 0.27 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 0.44 |
| Net Income Twelve Trailing Months | 9,732,000 |
| Net Income Past Year | 9,732,000 |
| Net Income Prior Year | 17,048,000 |
| Quarterly Revenue Growth YOY | -3.10% |
| 5-Year Revenue Growth | 42.01% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 44,579,000 |
| Total Cash Past Year | 44,579,000 |
| Total Cash Prior Year | 20,144,000 |
| Net Cash Position Most Recent Quarter | -13,026,000 |
| Net Cash Position Past Year | -13,026,000 |
| Long Term Debt Past Year | 57,605,000 |
| Long Term Debt Prior Year | 5,293,000 |
| Total Debt Most Recent Quarter | 57,605,000 |
| Equity to Debt Ratio Past Year | 0.44 |
| Equity to Debt Ratio Most Recent Quarter | 0.44 |
| Total Stockholder Equity Past Year | 46,129,000 |
| Total Stockholder Equity Prior Year | 66,358,000 |
| Total Stockholder Equity Most Recent Quarter | 46,129,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.28 |
| MACD Signal | -0.17 |
| 20-Day Bollinger Lower Band | 9.80 |
| 20-Day Bollinger Middle Band | 11.68 |
| 20-Day Bollinger Upper Band | 13.56 |
| Beta | 0.45 |
| RSI | 37.99 |
| 50-Day SMA | 9.84 |
| 200-Day SMA | 11.39 |
System |
|
| Modified | 4/25/2024 3:43:57 PM EST |